Leptin and cardiovascular disease: response to therapeutic interventions
about
Measuring adiposity in patients: the utility of body mass index (BMI), percent body fat, and leptinSystematic Review of Metabolic Syndrome Biomarkers: A Panel for Early Detection, Management, and Risk Stratification in the West Virginian PopulationChito-oligosaccharide inhibits the de-methylation of a 'CpG' island within the leptin (LEP) promoter during adipogenesis of 3T3-L1 cellsObesity and cardiovascular disease: friend or foe?Adipokine profile and urinary albumin excretion in isolated growth hormone deficiencyLeveraging leptin for type I diabetes?Role of vascular oxidative stress in obesity and metabolic syndrome.Distinct vascular and metabolic effects of different classes of anti-hypertensive drugs.Co-Administration of Metformin and N-Acetyl Cysteine Fails to Improve Clinical Manifestations in PCOS Individual Undergoing ICSI.Opposing roles of leptin and ghrelin in the equine corpus luteum regulation: an in vitro studyAdipocytokines, insulin resistance, and coronary atherosclerosis in rheumatoid arthritis.Adipokines and vascular health in treated HIV infection: an obesity paradox?Combination therapy for treatment or prevention of atherosclerosis: focus on the lipid-RAAS interactionUrinary cystatin C as a potential risk marker for cardiovascular disease and chronic kidney disease in patients with obesity and metabolic syndromeA comparison of novel and commonly-used indices of insulin sensitivity in African American chronic hemodialysis patientsPharmacological effects of lipid-lowering drugs on circulating adipokines.Modulation of leptin levels by oxidized linoleic acid: a connection to atherosclerosis?Lipid, adipokine and ghrelin levels in myocardial infarction patients with insulin resistance.Cardiac NO signalling in the metabolic syndrome.Pollock oil supplementation modulates hyperlipidemia and ameliorates hepatic steatosis in mice fed a high-fat diet.Effects of regular exercise on obesity and type 2 diabete mellitus in Korean children: improvements glycemic control and serum adipokines levelBrown adipose tissue: endocrine determinants of function and therapeutic manipulation as a novel treatment strategy for obesity.Adiponectin, leptin, and yoga practice.Effect of apolipoprotein E (APO E) polymorphism on leptin in Alzheimer's disease.Leptin levels predict survival in pulmonary arterial hypertension.Adipokines, diabetes and atherosclerosis: an inflammatory association.Leptin treatment inhibits the progression of atherosclerosis by attenuating hypercholesterolemia in type 1 diabetic Ins2(+/Akita):apoE(-/-) mice.Type 2 diabetes enhances arterial uptake of choline in atherosclerotic mice: an imaging study with positron emission tomography tracer ¹⁸F-fluoromethylcholineBetter prognosis in overweight/obese coronary heart disease patients with high plasma levels of leptin.Obesity-induced increases in sympathetic nerve activity: sex mattersIn vitro effects of sodium nitroprusside and leptin on norepinephrine-induced vasoconstriction in human internal mammary artery.How to estimate fat mass in overweight and obese subjects.Biological relevance of inflammation and oxidative stress in the pathogenesis of arterial diseases.Aliskiren effect on plaque progression in established atherosclerosis using high resolution 3D MRI (ALPINE): a double-blind placebo-controlled trial.Adipocytokines and the metabolic complications of obesity.Serum Concentrations of Leptin and Adiponectin in Dogs with Myxomatous Mitral Valve Disease.Inflammation and hypertension in rheumatoid arthritisDifferential metabolic effects of pravastatin and simvastatin in hypercholesterolemic patients.Obesity, Serum Resistin and Leptin Levels Linked to Coronary Artery Disease.Leptin and adiponectin as predictors of cardiovascular risk after gestational diabetes mellitus.
P2860
Q21090935-F79C1D0A-F822-4002-9B8F-FED193C49A4FQ26774109-B840299E-563B-4BEE-BF72-E9CD55F85923Q28489054-C04EECF3-042F-4033-9EF0-BEFDDD208411Q30251999-6415980E-CABD-4127-A9B2-942CFD870406Q33736161-5C1CBA0F-6B42-42EA-974D-C3390F9278BBQ33739927-1729C750-7A7D-4D46-ACFC-1C656A59B52BQ33789308-1BDE418C-A403-4FB7-8F26-04692D7E85C3Q33821236-EC6C5D14-9251-4C76-BF7F-ACC15F944FCAQ33937237-C9ADC71B-6BAF-4FD6-A9A0-3E10EEFBA5C7Q34003502-48778971-FF91-4E41-A881-25C8C2C7FB77Q34021686-49E24B65-4A59-4988-B22A-4BA651CA2011Q34075808-0FC00AB4-A32A-4B15-A58F-9D8A1F20AFA4Q34231611-5CB9FCD0-7D65-4AB0-AAD0-4CC030EF3A92Q34639560-DA27BA1D-660F-4D0B-8034-FE74E8CA5964Q34751835-F3C51EB7-9BC0-4704-A1E3-7E02612064A0Q34877922-3D08FBD4-B57B-4F31-82CB-350E891BE1B0Q35070079-E9AF8649-C1BE-4FBD-93DD-7E81F69A2049Q35085434-9DAE584C-C2A3-484F-87EC-A54987F7421AQ35204828-87FF9BBD-AE81-436B-83C1-99DDF46BCC0CQ35549836-032570C8-B858-4939-801A-9F30405FAA30Q35845069-B0C7B5B2-10B1-4924-AE8A-76DA3A43CF91Q35943980-0119F9D6-A747-4556-961E-C6FC73A2D033Q35954747-A5F06E1B-01E3-4A96-9955-B2214C3702CAQ36043033-E4CC642A-80E5-4134-B5B0-888D2149C092Q36108060-C3D62D4D-00A1-4F43-9666-A74F9E44864AQ36241112-D5A32B32-C6CF-4405-870C-38CA56DD7E31Q36413085-BC933A7F-8137-4BF9-BEBC-721A948D09FBQ36553346-A87CAE21-4B6E-41B4-A0A4-85817550DB3EQ36649341-26F58EEC-B205-440B-9B9C-679865000AF3Q36672718-FC84D938-C6A4-478F-86D8-C229E5DDE58FQ36747901-076E5F54-4866-4055-A344-F2D3C970D393Q36804775-8CFB03EC-F201-4DA9-A65E-B7E284F69789Q36817578-39D53D71-2C79-4322-BC42-4A26D151EA36Q36974370-98240248-1236-4924-BB61-3E3FFF58F9B9Q36979754-83C3816B-0769-4FBD-99A1-A3A31F72438BQ37275149-88FF4BBF-70DF-4C51-84D6-05B6F1901FC9Q37281848-62CF80E8-15D5-4F2B-B668-8FB06CC748EFQ37362218-40D8AF68-DE9B-4B2C-9BC8-A4540820CB90Q37404279-0E7763EE-8A17-4098-8B08-D69A803AEF9CQ37576401-5E68C33C-897A-4BC6-AA02-F933A7449579
P2860
Leptin and cardiovascular disease: response to therapeutic interventions
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Leptin and cardiovascular disease: response to therapeutic interventions
@en
Leptin and cardiovascular disease: response to therapeutic interventions.
@nl
type
label
Leptin and cardiovascular disease: response to therapeutic interventions
@en
Leptin and cardiovascular disease: response to therapeutic interventions.
@nl
prefLabel
Leptin and cardiovascular disease: response to therapeutic interventions
@en
Leptin and cardiovascular disease: response to therapeutic interventions.
@nl
P2860
P1433
P1476
Leptin and cardiovascular disease: response to therapeutic interventions
@en
P2093
Kwang Kon Koh
Sang Min Park
P2860
P304
P356
10.1161/CIRCULATIONAHA.107.741645
P407
P577
2008-06-01T00:00:00Z